029-83533393
   info@TaiBSbio.com
 
组织芯片,组织微阵列
 
FOV1006卵巢癌组织芯片,附病理分级、TNM和临床分期,100例/100点
Zoom
点 数100例 数100
行 数10列 数10
点直径(mm)1.0厚度(µm)5.0
组织阵列类型石蜡包埋种 属人类
QA/QCH&E and IHC confirmed
ApplicationsRoutine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better.

2.Bake the slides for 30 minutes at 60℃ before the experiment;

3.Please choose a gentle repair method to avoid tissue detachment.

产品名:FOV1006
 
卵巢癌组织微阵列芯片,包含浆液性腺癌30例,粘液腺癌20例,子宫内膜样腺癌10例,透明细胞癌6例,内胚窦瘤和颗粒细胞瘤各2例,边缘组织30例,一例一点
 
 
询价  Tel: 029-83533393
 
下载说明书
 
 
Legend:
Ova
-Ovary
 
Malignant (I)
 
Malignant (IA)
 
Malignant (IB)
 
Malignant (IC)
 
Malignant (II)
 
Malignant (IIB)
 
Malignant (III)
 
Malignant (IIIA)
 
Malignant (IIIC)
 
NAT (I)
 
NAT (IA)
 
NAT (IB)
 
NAT (IC)
 
NAT (II)
 
NAT (III)
 
NAT (IIIA)
TISSUE  ARRAYS FOV1006
1
2
3
4
5
6
7
8
9
10
A
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
B
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
C
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
D
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
E
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
F
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
G
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
H
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
I
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
J
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
 
PosNoAgeSexOrgan_Anatomic_SitePathology_diagnosisGradeTNMStageTypeTumor SizeisBackUp
A1123FOvarySerous adenocarcinoma1T2bN0M0IIBMalignant2.8*2*1.5N
A2243FOvarySerous adenocarcinoma2T3N1M0IIIAMalignant13*10*5N
A3358FOvarySerous adenocarcinoma2T1N0M0IMalignant10*10*7N
A4455FOvarySerous adenocarcinoma (sparse)2T1CN0M0ICMalignant*N
A5545FOvarySerous adenocarcinoma2T1AN0M0IAMalignant*N
A6645FOvarySerous adenocarcinoma2T3cN0M0IIICMalignant*N
A7758FOvarySerous adenocarcinoma (sparse)2T3cN0M0IIICMalignant*N
A8847FOvarySerous adenocarcinoma3T1N0M0IMalignant*N
A9923FOvarySerous adenocarcinoma3T3aN0M0IIIAMalignant10*10*5N
A101060FOvarySerous adenocarcinoma3T1BN0M0IBMalignant*N
B11167FOvarySerous adenocarcinoma3T1N0M0IMalignant13*12*6N
B21267FOvarySerous adenocarcinoma3T1AN0M0IAMalignant9*6*5.5N
B31339FOvarySerous adenocarcinoma2--3T3cN0M0IIICMalignant6*4*4N
B41453FOvarySerous adenocarcinoma with necrosis3T1N0M0IMalignant9*6*5N
B51553FOvarySerous adenocarcinoma3T3N1M0IIIAMalignant3*2*1N
B61656FOvarySerous adenocarcinoma3T1aN0M0IAMalignant12*7*7N
B71766FOvarySerous adenocarcinoma3T2bN0M0IIBMalignant7*7*4N
B81841FOvarySerous adenocarcinoma3T1N0M0IMalignant8*5*2N
B91921FOvarySerous adenocarcinoma3T1cN0M0ICMalignant13*9*4N
B102045FOvarySerous adenocarcinoma3T1aN0M0IAMalignant*N
C12125FOvarySerous adenocarcinoma with sparse necrosis3T1aN0M0IAMalignant*N
C22252FOvarySerous adenocarcinoma3T1aN0M0IAMalignant*N
C32361FOvarySerous adenocarcinoma with sparse necrosis3T3cN0M0IIICMalignant*N
C42465FOvarySerous adenocarcinoma3T1aN0M0IAMalignant*N
C52543FOvarySerous adenocarcinoma3T1aN0M0IAMalignant*N
C62658FOvarySerous adenocarcinoma3T3cN0M0IIICMalignant*N
C72748FOvarySerous adenocarcinoma with sparse necrosis3T1aN0M0IAMalignant*N
C82827FOvarySerous adenocarcinoma3T3cN0M0IIICMalignant*N
C92940FOvarySerous adenocarcinoma3T1AN0M0IAMalignant*N
C103037FOvarySerous adenocarcinoma3T1aN0M0IAMalignant*N
D13154FOvaryMucinous adenocarcinoma1T1bN0M0IBMalignant*N
D23234FOvaryMucinous adenocarcinoma1T1bN0M0IBMalignant*N
D33335FOvaryMucinous adenocarcinoma2T1BN0M0IBMalignant*N
D43450FOvaryMucinous adenocarcinoma (sparse)2T1aN0M0IAMalignant12*9*6N
D53540FOvaryMucinous adenocarcinoma2T1CN0M0ICMalignant*N
D63635FOvaryMucinous adenocarcinoma with sparse necrosis2T3aN1M0IIIAMalignant24*16*9N
D73724FOvaryMucinous adenocarcinoma with necrosis2T3N0M0IIIMalignant*N
D83852FOvaryMucinous adenocarcinoma with sparse necrosis2T1AN0M0IAMalignant*N
D93957FOvaryMucinous adenocarcinoma2T1BN0M0IBMalignant10*10N
D104067FOvaryMucinous adenocarcinoma (sparse)2T1N0M0IMalignant*N
E14156FOvaryMucinous adenocarcinoma2T1N0M0IMalignant9*8*5N
E24249FOvaryMucinous adenocarcinoma2T1aN0M0IAMalignant5*4*3.5N
E34334FOvaryMucinous adenocarcinoma2T1N0M0IMalignant6.2*4.3*3N
E44443FOvaryMucinous adenocarcinoma1--2T3cN0M0IIICMalignant6*4*2.5N
E54545FOvaryMucinous adenocarcinoma3T1aN0M0IAMalignant*N
E64661FOvaryMucinous adenocarcinoma3T1CN0M0ICMalignant*N
E74750FOvaryMucinous adenocarcinoma3T2N0M0IIMalignant7*4*4N
E84853FOvaryMucinous adenocarcinoma3T1N0M0IMalignant7*4*2.5N
E94948FOvaryMucinous adenocarcinoma (sparse)3T3aN0M0IIIAMalignant7*4*2.5N
E105038FOvaryMucinous adenocarcinoma3T1N0M0IMalignant11*8*4N
F15154FOvaryEndometrioid adenocarcinoma1T1BN0M0IBMalignant4.5*2.5*2N
F25254FOvaryEndometrioid adenocarcinoma1T1cN0M0ICMalignant18*13*8N
F35333FOvaryEndometrioid adenocarcinoma2T1N0M0IMalignant7*5*4N
F45460FOvaryEndometrioid adenocarcinoma2T3N0M0IIIMalignant*N
F55549FOvaryEndometrioid adenocarcinoma2T1AN0M0IAMalignant12*11*5N
F65655FOvaryEndometrioid adenocarcinoma2--3T1CN0M0ICMalignant13*10*5.5N
F75730FOvaryEndometrioid adenocarcinoma3T1N0M0IMalignant16*9*7N
F85858FOvaryEndometrioid adenocarcinoma with necrosis3T1aN0M0IAMalignant*N
F95955FOvaryEndometrioid adenocarcinoma with sparse necrosis3T1aN0M0IAMalignant*N
F106075FOvaryEndometrioid adenocarcinoma3T1N0M0IMalignant5*4*3N
G16143FOvaryClear cell carcinoma2T1aN0M0IAMalignant7*4*3N
G26261FOvaryClear cell carcinoma3T1aN0M0IAMalignant12*6*6N
G36342FOvaryClear cell carcinoma2T1aN0M0IAMalignant9.5*5*1N
G46453FOvaryClear cell carcinoma2T1bN0M0IBMalignant10*7*2N
G56540FOvaryClear cell carcinoma2T3cN0M0IIICMalignant*N
G66654FOvaryClear cell carcinoma3T2N0M0IIMalignant*N
G76714FOvaryEndoderm sinus tumor*T1cN0M0ICMalignant15*13*10N
G86833FOvaryEndoderm sinus tumor*T1N0M0IMalignant13*7*5N
G96984FOvaryGranulosa cell tumor*T1aN0M0IAMalignant10*6*0.8N
G107049FOvaryGranulosa cell tumor*T1N0M0IMalignant8*7*6N
H17136FOvaryAdjacent normal ovary tissue*T1N0M0INAT*N
H27253FOvaryAdjacent normal ovary tissue*T1bN0M0IBNAT*N
H37354FOvaryAdjacent normal ovary tissue*T1bN0M0IBNAT*N
H47464FOvaryAdjacent normal ovary tissue*T1aN0M0IANAT*N
H57552FOvaryAdjacent normal ovary tissue*T3aN1M0IIIANAT*N
H67657FOvaryAdjacent normal ovary tissue*T1aN0M0IANAT*N
H77751FOvaryAdjacent normal ovary tissue*T1aN0M0IANAT*N
H87850FOvaryAdjacent normal ovary tissue*T3N0M0IIINAT*N
H97935FOvaryAdjacent normal ovary tissue*T1aN0M0IANAT*N
H108042FOvaryAdjacent normal ovary tissue*T1aN0M0IANAT*N
I18151FOvaryAdjacent normal ovary tissue*T1aN1M0IIIANAT*N
I28238FOvaryAdjacent normal ovary tissue*T2bN1M0IIIANAT*N
I38350FOvaryAdjacent normal ovary tissue*T1bN0M0IBNAT*N
I48444FOvaryAdjacent normal ovary tissue*T1bN0M0IBNAT*N
I58547FOvaryAdjacent normal ovary tissue*T1bN0M0IBNAT*N
I68665FOvaryAdjacent normal ovary tissue*T1N0M0INAT*N
I78728FOvaryAdjacent normal ovary tissue*T1bN0M0IBNAT*N
I88844FOvaryAdjacent normal ovary tissue*T1bN0M0IBNAT*N
I98945FOvaryAdjacent normal ovary tissue*T1aN0M0IANAT*N
I109062FOvaryAdjacent normal ovary tissue*T3aN1M0IIIANAT*N
J19156FOvaryAdjacent normal ovary tissue*T1aN0M0IANAT*N
J29236FOvaryAdjacent normal ovary tissue*T1cN0M0ICNAT*N
J39347FOvaryAdjacent normal ovary tissue*T1N0M0INAT*N
J49451FOvaryAdjacent normal ovary tissue*T1aN0M0IANAT*N
J59558FOvaryAdjacent normal ovary tissue*T1aN0M0IANAT*N
J69644FOvaryAdjacent normal ovary tissue*T1aN0M0IANAT*N
J79749FOvaryAdjacent normal ovary tissue*T1N0M0INAT*N
J89855FOvaryAdjacent normal ovary tissue*T1cN0M0ICNAT*N
J99951FOvaryAdjacent normal ovary tissue*T2N0M0IINAT*N
J1010051FOvaryAdjacent normal ovary tissue*T1aN0M0IANAT*N
Tissue Marker
 
 
西安泰博斯生物科技有限公司

 
联系我们
地址:陕西西安市灞桥区长乐东路2999号
电话:029-83533393, 17792711553,
电子邮箱:taibsbio@163.com
QQ:3144647811
微信号:13002913390
邮政编码:710075
关于我们
西安泰博斯生物科技有限公司主要经营组织芯片的研发、销售,加工定制和与组织芯片有关的生物技术服务项目。公司目前拥有专业的病理医生和技术研发团队,并且具有庞大的组织标本库。样本库中组织微阵列种类多,病理类型齐全,同时根据客户需求情况进行制作加工新的组织微阵列,尽量满足每一个客户的需求。公司一直秉承着“认真、严谨、负责”的工作态度,致力于为广大客户提供质量好的产品和优质的服务。

更多详情